Combining Ezetimibe and Rosuvastatin: Impacts on Insulin Sensitivity and Vascular Inflammation in Patients with Type 2 Diabetes Mellitus.
作者信息
Roh Eun
机构信息
Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.
出版信息
Diabetes Metab J. 2024 Jan;48(1):55-58. doi: 10.4093/dmj.2023.0442. Epub 2024 Jan 29.
Abstract
摘要
相似文献
1
Combining Ezetimibe and Rosuvastatin: Impacts on Insulin Sensitivity and Vascular Inflammation in Patients with Type 2 Diabetes Mellitus.
Diabetes Metab J. 2024 Jan;48(1):55-58. doi: 10.4093/dmj.2023.0442. Epub 2024 Jan 29.
2
Effects of rosuvastatin/ezetimibe on senescence of CD8+ T-cell in type 2 diabetic patients with hypercholesterolemia: A study protocol.
Medicine (Baltimore). 2022 Nov 25;101(47):e31691. doi: 10.1097/MD.0000000000031691.
3
Effect of fixed-dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS-ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe).
Cardiovasc Ther. 2016 Oct;34(5):371-82. doi: 10.1111/1755-5922.12213.
4
5
An overview of rosuvastatin/ezetimibe association for the treatment of hypercholesterolemia and mixed dyslipidemia.
Expert Opin Pharmacother. 2020 Apr;21(5):531-539. doi: 10.1080/14656566.2020.1714028. Epub 2020 Feb 8.
6
Combination therapy analysis of ezetimibe and statins in Chinese patients with acute coronary syndrome and type 2 diabetes.
Lipids Health Dis. 2015 Feb 18;14:10. doi: 10.1186/s12944-015-0004-7.
7
Effect of cholesterol-lowering agents on soluble epidermal growth factor receptor level in type 2 diabetes and hypercholesterolemia.
Medicine (Baltimore). 2022 Aug 26;101(34):e30287. doi: 10.1097/MD.0000000000030287.
8
Rosuvastatin/Ezetimibe: A Review in Hypercholesterolemia.
Am J Cardiovasc Drugs. 2020 Aug;20(4):381-392. doi: 10.1007/s40256-020-00421-1.
9
Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients.
Lipids Health Dis. 2015 Jun 19;14:57. doi: 10.1186/s12944-015-0054-x.
10
The effect of lipid-lowering therapies on the pro-inflammatory and anti-inflammatory properties of vascular endothelial cells.
PLoS One. 2023 Feb 8;18(2):e0280741. doi: 10.1371/journal.pone.0280741. eCollection 2023.
引用本文的文献
1
The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies.
Metabolites. 2024 Jul 17;14(7):388. doi: 10.3390/metabo14070388.
本文引用的文献
1
Comparative Efficacy of Rosuvastatin Monotherapy and Rosuvastatin/Ezetimibe Combination Therapy on Insulin Sensitivity and Vascular Inflammatory Response in Patients with Type 2 Diabetes Mellitus.
Diabetes Metab J. 2024 Jan;48(1):112-121. doi: 10.4093/dmj.2022.0402. Epub 2024 Jan 3.
2
Lipid Management in Korean People With Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement.
J Lipid Atheroscler. 2023 Jan;12(1):12-22. doi: 10.12997/jla.2023.12.1.12. Epub 2023 Jan 17.
3
Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics.
Signal Transduct Target Ther. 2022 Aug 2;7(1):265. doi: 10.1038/s41392-022-01125-5.
4
Molecular Biological and Clinical Understanding of the Statin Residual Cardiovascular Disease Risk and Peroxisome Proliferator-Activated Receptor Alpha Agonists and Ezetimibe for Its Treatment.
Int J Mol Sci. 2022 Mar 22;23(7):3418. doi: 10.3390/ijms23073418.
5
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
6
Impact of decreased insulin resistance by ezetimibe on postprandial lipid profiles and endothelial functions in obese, non-diabetic-metabolic syndrome patients with coronary artery disease.
Heart Vessels. 2019 Jun;34(6):916-925. doi: 10.1007/s00380-018-1319-x. Epub 2018 Dec 5.
7
Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study.
Sci Rep. 2018 Aug 9;8(1):11925. doi: 10.1038/s41598-018-30409-6.
8
Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis.
Endocrinol Metab (Seoul). 2018 Jun;33(2):219-227. doi: 10.3803/EnM.2018.33.2.219. Epub 2018 May 4.
9
Effect of ezetimibe on glycemic control: a systematic review and meta-analysis of randomized controlled trials.
Endocrine. 2018 May;60(2):229-239. doi: 10.1007/s12020-018-1541-4. Epub 2018 Feb 3.
10
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
Circulation. 2018 Apr 10;137(15):1571-1582. doi: 10.1161/CIRCULATIONAHA.117.030950. Epub 2017 Dec 20.
Zotero 插件